About
Gene Therapy Development
Areas of Focus
Categories
Gene Therapy, RNA & Peptide TherapyChina
Team (4)
Clinical Trials (7)
View allTotal Trials
7
As Lead Sponsor
7
As Collaborator
0
Total Enrollment
251
By Phase
PHASE1/PHASE2: 4PHASE1: 2EARLY_PHASE1: 1
By Status
RECRUITING: 6NOT_YET_RECRUITING: 1
Clinical Trials Pipeline7 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
Today
Hover over trial bars to see details
Recent Trials
NCT06492850Lead Sponsor
Gene Therapy for RPGR Gene Mutation-associated X-linked Retinitis Pigmentosa
PHASE1/PHASE2Recruiting
32 participants
Started: Apr 1, 2024 · Completed: Feb 1, 2026
NCT06492876Lead Sponsor
Gene Therapy for DME
PHASE1/PHASE2Recruiting
78 participants
Started: Nov 15, 2023 · Completed: Nov 15, 2028
NCT06492863Lead Sponsor
Gene Therapy(FT-003) for Wet AMD
PHASE1/PHASE2Recruiting
78 participants
Started: Aug 15, 2023 · Completed: Oct 15, 2028
NCT05916391Lead Sponsor
Gene Therapy for Diabetic Macular Edema
PHASE1Recruiting
18 participants
Started: May 19, 2023 · Completed: May 1, 2028
NCT05611424Lead Sponsor
Gene Therapy for Wet AMD
PHASE1Not yet recruiting
18 participants
Started: May 1, 2023 · Completed: Dec 30, 2027
Locations (1)
Headquarters
Suzhou, China
Map
Loading map...